1. Home
  2. EVO vs AFYA Comparison

EVO vs AFYA Comparison

Compare EVO & AFYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVO
  • AFYA
  • Stock Information
  • Founded
  • EVO 1993
  • AFYA 1999
  • Country
  • EVO Germany
  • AFYA Brazil
  • Employees
  • EVO N/A
  • AFYA N/A
  • Industry
  • EVO Biotechnology: Pharmaceutical Preparations
  • AFYA Other Consumer Services
  • Sector
  • EVO Health Care
  • AFYA Real Estate
  • Exchange
  • EVO Nasdaq
  • AFYA Nasdaq
  • Market Cap
  • EVO 1.5B
  • AFYA 1.7B
  • IPO Year
  • EVO 2021
  • AFYA 2019
  • Fundamental
  • Price
  • EVO $4.34
  • AFYA $17.54
  • Analyst Decision
  • EVO Buy
  • AFYA Sell
  • Analyst Count
  • EVO 2
  • AFYA 5
  • Target Price
  • EVO $5.90
  • AFYA $17.60
  • AVG Volume (30 Days)
  • EVO 120.0K
  • AFYA 116.2K
  • Earning Date
  • EVO 08-13-2025
  • AFYA 08-15-2025
  • Dividend Yield
  • EVO N/A
  • AFYA 1.40%
  • EPS Growth
  • EVO N/A
  • AFYA 41.32
  • EPS
  • EVO N/A
  • AFYA 1.31
  • Revenue
  • EVO $851,944,444.00
  • AFYA $599,363,389.00
  • Revenue This Year
  • EVO $10.08
  • AFYA $15.52
  • Revenue Next Year
  • EVO $10.99
  • AFYA $8.72
  • P/E Ratio
  • EVO N/A
  • AFYA $13.77
  • Revenue Growth
  • EVO 1.50
  • AFYA 15.70
  • 52 Week Low
  • EVO $2.84
  • AFYA $14.52
  • 52 Week High
  • EVO $5.64
  • AFYA $19.90
  • Technical
  • Relative Strength Index (RSI)
  • EVO 57.99
  • AFYA 43.67
  • Support Level
  • EVO $4.15
  • AFYA $17.33
  • Resistance Level
  • EVO $4.33
  • AFYA $18.16
  • Average True Range (ATR)
  • EVO 0.11
  • AFYA 0.50
  • MACD
  • EVO 0.02
  • AFYA 0.01
  • Stochastic Oscillator
  • EVO 85.92
  • AFYA 33.27

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

About AFYA Afya Limited

Afya Ltd is a medical education group based in Brazil. Its education portfolio has several courses in addition to Medicine, such as Management, Dentistry, Law, Engineering, Nursing, Psychology, and Accounting Sciences, among others. It has three segments; Undergrad provides educational services through undergraduate courses related to medical school, undergraduate health science and other ex-health undergraduate programs, Continuing Education provides medical education, specialization and graduate courses in medicine, delivered through digital and in-person content; and Medical practice solution provides clinical decision, clinical management and doctor-patient relationships for physicians and provide access, demand and efficiency for the healthcare players.

Share on Social Networks: